These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34067214)

  • 1. Differentiated Thyroid Cancer: A Health Economic Review.
    Van Den Heede K; Tolley NS; Di Marco AN; Palazzo FF
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34067214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.
    Lang BH; Wong CK; Chan CT
    Eur J Surg Oncol; 2015 Jun; 41(6):758-65. PubMed ID: 25680952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis.
    Drozd V; Saenko V; Branovan DI; Brown K; Yamashita S; Reiners C
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33810323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J; Weehuizen R; Mavranezouli I; Mihalopoulos C; Smit F
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost Effectiveness of Lenvatinib, Sorafenib and Placebo in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Wilson L; Huang W; Chen L; Ting J; Cao V
    Thyroid; 2017 Aug; 27(8):1043-1052. PubMed ID: 28486081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated thyroid cancer: millions spent with no tangible gain?
    Furuya-Kanamori L; Sedrakyan A; Onitilo AA; Bagheri N; Glasziou P; Doi SAR
    Endocr Relat Cancer; 2018 Jan; 25(1):51-57. PubMed ID: 29042396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Bowles EJA; Williams SB; Morrison CC
    JAMA; 2017 May; 317(18):1888-1903. PubMed ID: 28492904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
    Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
    Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review.
    Anderson RT; Linnehan JE; Tongbram V; Keating K; Wirth LJ
    Thyroid; 2013 Apr; 23(4):392-407. PubMed ID: 23294230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical options for thyroid cancer and post-surgical management.
    Doubleday A; Sippel RS
    Expert Rev Endocrinol Metab; 2018 May; 13(3):137-148. PubMed ID: 30058897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Trends and Factors Associated with Hospital Costs Following Thyroid Surgery.
    Biron VL; Bang H; Farwell DG; Bewley AF
    Thyroid; 2015 Jul; 25(7):823-9. PubMed ID: 25873398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment.
    Nickel B; Tan T; Cvejic E; Baade P; McLeod DSA; Pandeya N; Youl P; McCaffery K; Jordan S
    JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):231-238. PubMed ID: 30653212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attributable costs of differentiated thyroid cancer in the elderly Medicare population.
    Boltz MM; Hollenbeak CS; Schaefer E; Goldenberg D; Saunders BD
    Surgery; 2013 Dec; 154(6):1363-9; discussion 1369-70. PubMed ID: 23973115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost for treatment and follow-up of thyroid cancer increases according to the severity of disease.
    Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Kwon SS; Shin H; Chang HS; Park CS
    Head Neck; 2019 Jul; 41(7):2376-2379. PubMed ID: 30784141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
    Jensen CB; Saucke MC; Francis DO; Voils CI; Pitt SC
    Thyroid; 2020 May; 30(5):696-703. PubMed ID: 31910092
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid cancer: burden of illness and management of disease.
    Brown RL; de Souza JA; Cohen EE
    J Cancer; 2011 Apr; 2():193-9. PubMed ID: 21509149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.